Cargando…
Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag)
The aim was to assess the bioequivalence of Sandoz methylphenidate osmotic-controlled release (OCR) tablets (Sandoz [Methylphenidate[ MPH OCR) with Concerta®, a methylphenidate formulation indicated for the treatment of attention deficit/hyperactivity disorder (ADHD). Four open-label, randomized, si...
Autores principales: | Schapperer, Elisabeth, Daumann, Heike, Lamouche, Stéphane, Thyroff-Friesinger, Ursula, Viel, François, Weitschies, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317218/ https://www.ncbi.nlm.nih.gov/pubmed/25692005 http://dx.doi.org/10.1002/prp2.72 |
Ejemplares similares
-
Competition for clinical cases in Alzheimer’s disease (CCCAD) –
Janssen-Cilag
Publicado: (2008) -
Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults
por: Fey, Constanze, et al.
Publicado: (2014) -
Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial
por: Sörgel, Fritz, et al.
Publicado: (2009) -
Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study
por: Fife, Daniel, et al.
Publicado: (2018) -
Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions
por: Davanço, Marcelo Gomes, et al.
Publicado: (2023)